Ciglitazone Ciglitazone born in 1980 and is considered to be the prototypical of TZDs, indeed was never used as a medication
It is a targeted, three-organism system
10.1016/j.tins.2017.04.002 Trends Neurosci
The pill is also approved to help reduce the risk of serious cardiovascular events like nonfatal heart attacks and strokes
[1] When patients take GLP-1 receptor agonists, healthcare providers typically monitor several blood parameters to assess treatment efficacy and safety, though none of these tests directly measure the GLP-1 medication itself
Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai Li, Grubert F et al (2009) The Genetic Architecture of Down Syndrome Phenotypes Revealed by High-Resolution Analysis of Human Segmental Trisomies